![Tibor Keler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tibor Keler
Oprichter bij
CELLDEX THERAPEUTICS, INC.
Vermogen: 231 231 $ op 31-05-2026
Profiel
Tibor Keler is the founder of Celldex Therapeutics, Inc., founded in 1983, holding the title of Chief Scientific Officer & Executive VP.
The current job is Chief Scientific Officer, VP-Research & Discovery at Celldex Research Corp.
since 2003.
Former jobs include Senior Director-Preclinical Development at Medarex, Inc. from 2003 to 2004, Chief Scientific Officer & Senior Vice President at AVANT Immunotherapeutics, Inc. in 2008, and Chief Scientific Officer, VP-Research & Discovery at Celldex Therapeutics, Inc. (Old) from 2003 to 2008.
Education includes a doctorate from the University of Pennsylvania and undergraduate and graduate degrees from Drexel University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2026 | 7.357 ( 0,01% ) | 231 231 $ | 31-05-2026 |
Actieve functies van Tibor Keler
| Bedrijven | Functie | Begin |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Oprichter | 01-01-1983 |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Hoofd Techniek/Wetenschap/O&O | 01-05-2003 |
Eerdere bekende functies van Tibor Keler
| Bedrijven | Functie | Einde |
|---|---|---|
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Hoofd Techniek/Wetenschap/O&O | 01-10-2008 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-10-2008 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 01-03-2004 |
Opleiding van Tibor Keler
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
